Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
97,728
-
Share change
-
+63,682
-
Total reported value
-
$2,245,000
-
Price per share
-
$22.92
-
Number of holders
-
16
-
Value change
-
+$1,269,849
-
Number of buys
-
14
-
Number of sells
-
4
Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) as of Q4 2017
As of 31 Dec 2017,
OPIANT PHARMACEUTICALS INC - COM (OPNT) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,728 shares.
The largest 10 holders included
Venator Capital Management Ltd., Spark Investment Management LLC, OxFORD Asset Management LLP, Vanguard Group Inc, ACADIAN ASSET MANAGEMENT LLC, O'SHAUGHNESSY ASSET MANAGEMENT, LLC, MORGAN STANLEY, Tradewinds Capital Management, LLC, UBS Group AG, and LADENBURG THALMANN FINANCIAL SERVICES INC..
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.